SCHEMBL2200102

SCHEMBL2200102

COCCOc1ccc(C(=O)c2ccc(N)cc2Cl)c(C)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.46
TDP1 Q9NUW8 3/20 0.46
MAPK14 Q16539 2/20 0.45
BTK Q06187 2/20 0.43
NR1H4 Q96RI1 1/20 0.42
CHRM2 P08172 1/20 0.42
CHRM3 P20309 1/20 0.42
MAOA P21397 1/20 0.42
HTR2C P28335 1/20 0.42
CHRNA4 P43681 1/20 0.42
HTR3A P46098 1/20 0.42
KCNH2 Q12809 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42
MAPT P10636 3/20 0.41
RAB9A P51151 1/20 0.41
ALDH1A1 P00352 2/20 0.40
GAA P10253 1/20 0.40
CHEK2 O96017 1/20 0.40
MCL1 Q07820 1/20 0.40
HDAC8 Q9BY41 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2195369 0.88 NR1H4 (0.42) KDM4ETDP1MAPK14NR1H4CHRM2
SCHEMBL5176008 0.86 MAPT (0.50) KDM4ETDP1MAPK14NR1H4CHRM2
SCHEMBL5172405 0.84 RAB9A (0.54) MAPK14NR1H4CHRM2CHRM3MAOA
SCHEMBL2200085 0.82 NR1H4 (0.41) TDP1MAPK14NR1H4CHRM2CHRM3
SCHEMBL2198250 0.81 MAPK1 (0.61) KDM4ETDP1NR1H4MAPTRAB9A
SCHEMBL2197670 0.79 MEN1 (0.48) KDM4EBTKNR1H4CHRM2CHRM3
SCHEMBL2198410 0.78 MAPK14 (0.67) KDM4ETDP1MAPK14BTKHPGD
SCHEMBL2199085 0.77 MEN1 (0.53) KDM4EBTKNR1H4CHRM2CHRM3
SCHEMBL5174662 0.76 RAB9A (0.48) KDM4EMAPK14MAPTRAB9AALDH1A1
SCHEMBL16510358 0.76 MAOB (0.47) KDM4ETDP1MAPTGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166990-A1 Novel aminobenzophenone compounds NFKBIA, UACA, ALDH7A1 KDM4E 1532/4885TDP1 2935/4885MAPK14 697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.